Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GELA-Recherche Clinique (GELA-RC) was the clinical research operations arm of the Groupe d'Etude des Lymphomes de l'Adulte, a prominent French cooperative group dedicated to lymphoma research. The organization functioned as a specialized contract research organization (CRO) managing multicenter clinical trials focused on improving treatments for adult lymphoma patients. In 2012, GELA merged with the GOELAMS group to form LYSA (The Lymphoma Study Association), and GELA-RC's operations were integrated into LYSARC (The Lymphoma Academic Research Organisation). LYSARC now serves as the largest European academic structure dedicated to clinical research in the field of lymphoma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GELA-Recherche Clinique.